Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
ALTEX|November 20, 2013
An alternative QSAR-based approach for predicting the bioconcentration factor for regulatory purposesAndrea Gissi, Domenico Gadaleta, Matteo Floris, et al.
European Journal of Medicinal Chemistry|December 15, 2010
Synthesis and biophysical evaluation of arylhydrazono-1H-2-indolinones as β-amyloid aggregation inhibitorsFrancesco Campagna, Marco Catto, Rosa Purgatorio, et al.
The Open Medicinal Chemistry Journal|February 2, 2018
Synthesis and Biological Evaluation of Novel Hybrid Molecules Containing Purine, Coumarin and Isoxazoline or Isoxazole MoietiesMichael G Kallitsakis, Angelo Carotti, Marco Catto, et al.
Chemmedchem|August 3, 2010
Design, synthesis, and biological evaluation of coumarin derivatives tethered to an edrophonium-like fragment as highly potent and selective dual binding site acetylcholinesterase inhibitorsLeonardo Pisani, Marco Catto, Ilenia Giangreco, et al.
Bioorganic & Medicinal Chemistry|December 7, 2002
Coumarin, chromone, and 4(3H)-pyrimidinone novel bicyclic and tricyclic derivatives as antiplatelet agents: synthesis, biological evaluation, and comparative molecular field analysisGiorgio Roma, Mario Di Braccio, Antonio Carrieri, et al.
Plos One|October 15, 2011
Insights into the complex formed by matrix metalloproteinase-2 and alloxan inhibitors: molecular dynamics simulations and free energy calculationsIlenia Giangreco, Gianluca Lattanzi, Orazio Nicolotti, et al.
European Journal of Medicinal Chemistry|August 14, 2016
Quinolino[3,4-b]quinoxalines and pyridazino[4,3-c]quinoline derivatives: Synthesis, inhibition of topoisomerase IIα, G-quadruplex binding and cytotoxic propertiesFausta Palluotto, Alice Sosic, Odra Pinato, et al.
Bioorganic & Medicinal Chemistry|December 4, 2012
Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesteraseMarco Catto, Leonardo Pisani, Francesco Leonetti, et al.
European Journal of Medicinal Chemistry|June 30, 2014
Novel, potent and selective 17β-hydroxysteroid dehydrogenase type 2 inhibitors as potential therapeutics for osteoporosis with dual human and mouse activitiesEnrico Perspicace, Liliana Cozzoli, Emanuele M Gargano, et al.
Bioorganic & Medicinal Chemistry|March 27, 2017
Indenocinnoline derivatives as G-quadruplex binders, topoisomerase IIα inhibitors and antiproliferative agentsGrigoris Zoidis, Alice Sosic, Silvia Da Ros, et al.
Pageof 9